Protection of IFN-γ signaling-deficient NOD mice from diabetes by cyclophosphamide

International Immunology

Volumn 20, Issue 9, 2008, Pages 1231-1237

  Mori, Yoshiko ^a   Kato, Takako ^a   Kodaka, Tetsuro ^a   Kanagawa, Edith M ^a   Hori, Shohei ^a   Kanagawa, Osami ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Environmental factor; Genetic factor; Regulatory T cell; Type I diabetes

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; HEREDITY; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; IMMUNOLOGY; MOUSE MUTANT;

ANIMALS; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 53749083850     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn080     Document Type: Article

References (37)

1. Castano, L. and Eisenbarth, G. S. 1990. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647.
2. Kikutani, H. and Makino, S. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:285.
3. Wicker, L. S., Todd, J. A. and Peterson, L. B. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
4. Knip, M. 2003. Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes. Rev. Endocr. Metab. Disord. 4:213.
5. Todd, J. A., Bell, J. I. and McDevitt, H. O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599.
6. Hattori, M., Buse, J. B., Jackson, R. A. et al. 1986. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex. Science 231:733.
7. Colle, E., Guttmann, R. D. and Seemayer, T. 1981. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J. Exp. Med. 154:1237.
8. Todd, J. A. 1995. Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl Acad. Sci. USA 92:8560.
9. Adeghate, E., Schattner, P. and Dunn, E. 2006. An update on the etiology and epidemiology of diabetes mellitus. Ann. N. Y. Acad. Sci. 1084:1.
10. Pozzilli, P., Signore, A., Williams, A. J. and Beales, P. E. 1993. NOD mouse colonies around the world - recent facts and figures. Immunol. Today 14:193.
11. Akerblom, H. K., Vaarala, O., Hyoty, H., Ilonen, J. and Knip, M. 2002. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115:18.
12. Hypponen, E., Kenward, M. G., Virtanen, S. M. et al. 1999. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 22:1961.
13. Hyoty, H. and Taylor, K. W. 2002. The role of viruses in human diabetes. Diabetologia 45:1353.
14. Anderson, M. S. and Bluestone, J. A. 2005. The NOD mouse: A model of immune dysregulation. Annu. Rev. Immunol. 23: 447.
15. Yasunami, R. and Bach, J. F. 1988. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18:481.
16. Kanagawa, O., Xu, G., Tevaarwerk, A. and Vaupel, B. A. 2000. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci. J. Immunol. 164: 3919.
17. Wang, B., Andre, I., Gonzalez, A. et al. 1997. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl Acad. Sci. USA 94:13844.
18. Serreze, D. V., Chapman, H. D., Post, C. M., Johnson, E. A., Suarez-Pinzon, W. L. and Rabinovitch, A. 2001. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166:1352.
19. Serreze, D. V., Post, C. M., Chapman, H. D., Johnson, E. A., Lu, B. and Rothman, P. B. 2000. Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 49:2007.
20. Sarmiento, M., Loken, M. R. and Fitch, F. W. 1981. Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells. Hybridoma 1:13.
21. Wang, F., Huang, C. Y. and Kanagawa, O. 1998. Rapid deletion of rearranged T cell antigen receptor (TCR) Valpha-Jalpha segment by secondary rearrangement in the thymus: Role of continuous rearrangement of TCR alpha chain gene and positive selection in the T cell repertoire formation. Proc. Natl Acad. Sci. USA 95:11834.
22. Gotoh, M., Maki, T., Kiyoizumi, T., Satomi, S. and Monaco, A. P. 1985. An improved method for isolation of mouse pancreatic islets. Transplantation 40:437.
23. Ulaeto, D., Lacy, P. E., Kipnis, D. M., Kanagawa, O. and Unanue, E. R. 1992. A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc. Natl Acad. Sci. USA 89:3927.
24. Ceredig, R., Lowenthal, J. W., Nabholz, M. and MacDonald, H. R. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
25. Kanagawa, O., Militech, A. and Vaupel, B. A. 2002. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J. Immunol. 168:6159.
26. Hultgren, B., Huang, X., Dybdal, N. and Stewart, T. A. 1996. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812.
27. Wicker, L. S., Clark, J., Fraser, H. I. et al. 2005. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25:(Suppl)29.
28. Harada, M. and Makino, S. 1984. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604.
29. Brode, S., Raine, T., Zaccone, P. and Cooke, A. 2006. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177:6603.
30. Farrar, M. A. and Schreiber, R. D. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571.
31. Boehm, U., Klamp, T., Groot, M. and Howard, J. C. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749.
32. Matthys, P., Vermeire, K., Heremans, H. and Billiau, A. 2000. The protective effect of IFN-gamma in experimental autoimmune diseases: A central role of mycobacterial adjuvant-induced myelopoiesis. J. Leukoc. Biol. 68:447.
33. Rosloniec, E. F., Latham, K. and Guedez, Y. B. 2002. Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res. 4:333.
34. Skurkovich, S. and Skurkovich, B. 2005. Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases. Ann. N. Y. Acad. Sci. 1051:684.
35. Wan, Y. Y. and Flavell, R. A. 2006. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol. Rev. 212:114.
36. Lohr, J., Knoechel, B. and Abbas, A. K. 2006. Regulatory T cells in the periphery. Immunol. Rev. 212:149.
37. Bettelli, E., Carrier, Y., Gao, W. et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory Tcells. Nature 441:235.